Cell Biotech Co. Ltd (049960) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.033x

Based on the latest financial reports, Cell Biotech Co. Ltd (049960) has a cash flow conversion efficiency ratio of 0.033x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩4.15 Billion ≈ $2.81 Million USD) by net assets (₩127.11 Billion ≈ $86.14 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Cell Biotech Co. Ltd net asset quality index to measure how much of total assets are equity-financed.

Cell Biotech Co. Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Cell Biotech Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Cell Biotech Co. Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.

Cell Biotech Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cell Biotech Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Nordic Mining ASA OL:NOM	-0.323x
Gabriel Holding CO:GABR	0.144x
Orbitech Co. Ltd KQ:046120	-0.069x
Industri Dan Perdagangan Bintraco Dharma Tbk PT JK:CARS	0.014x
Exicon Co. Ltd KQ:092870	-0.041x
Fifth District Bancorp, Inc. Common Stock NASDAQ:FDSB	0.000x
Champions Oncology Inc NASDAQ:CSBR	-0.306x
Quantum Graphite Ltd AU:QGL	-0.115x

Annual Cash Flow Conversion Efficiency for Cell Biotech Co. Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Cell Biotech Co. Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see Cell Biotech Co. Ltd (049960) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩124.17 Billion ≈ $84.15 Million	₩19.27 Billion ≈ $13.06 Million	0.155x	+122.14%
2023-12-31	₩111.89 Billion ≈ $75.82 Million	₩7.82 Billion ≈ $5.30 Million	0.070x	-41.08%
2022-12-31	₩108.09 Billion ≈ $73.25 Million	₩12.81 Billion ≈ $8.68 Million	0.119x	-15.07%
2021-12-31	₩106.69 Billion ≈ $72.30 Million	₩14.89 Billion ≈ $10.09 Million	0.140x	+45.93%
2020-12-31	₩99.98 Billion ≈ $67.76 Million	₩9.56 Billion ≈ $6.48 Million	0.096x	-3.14%
2019-12-31	₩103.60 Billion ≈ $70.21 Million	₩10.23 Billion ≈ $6.93 Million	0.099x	-25.37%
2018-12-31	₩105.62 Billion ≈ $71.58 Million	₩13.98 Billion ≈ $9.47 Million	0.132x	-47.02%
2017-12-31	₩90.20 Billion ≈ $61.12 Million	₩22.53 Billion ≈ $15.27 Million	0.250x	+16.83%
2016-12-31	₩84.15 Billion ≈ $57.03 Million	₩17.99 Billion ≈ $12.19 Million	0.214x	-19.39%
2015-12-31	₩68.76 Billion ≈ $46.60 Million	₩18.24 Billion ≈ $12.36 Million	0.265x	+40.17%
2014-12-31	₩52.36 Billion ≈ $35.48 Million	₩9.91 Billion ≈ $6.71 Million	0.189x	-9.37%
2013-12-31	₩43.05 Billion ≈ $29.17 Million	₩8.99 Billion ≈ $6.09 Million	0.209x	+23.25%
2012-12-31	₩36.42 Billion ≈ $24.68 Million	₩6.17 Billion ≈ $4.18 Million	0.169x	-1.36%
2011-12-31	₩31.77 Billion ≈ $21.53 Million	₩5.45 Billion ≈ $3.70 Million	0.172x	--

About Cell Biotech Co. Ltd

KQ:049960 Korea Biotechnology & Medical Research

Market Cap

$79.89 Million

₩117.88 Billion KRW

Market Cap Rank

#19986 Global

#1013 in Korea

Share Price

₩15270.00

Change (1 day)

+0.20%

52-Week Range

₩11500.00 - ₩18110.00

All Time High

₩56579.38